| 12173026 |
PRMT5 inhibitors |
Michelle R. Machacek, David J. Witter, Craig R. Gibeau, Chunhui Huang, Shuhei Kawamura +15 more |
2024-12-24 |
| 10736908 |
Antiviral aryl-amide phosphodiamide compounds |
Jean-Laurent Paparin, Aurélien Salanson, Daniel Da Costa, David Dukhan, Timothy J. Hartingh +2 more |
2020-08-11 |
| 10519159 |
Antiviral aliphatic ester prodrugs of tenofovir |
Jean-Laurent Paparin, Izzat T. Raheem, Daniel Da Costa, David Dukhan |
2019-12-31 |
| 10513534 |
2′-chloro nucleoside analogs for HCV infection |
Gilles Gosselin, Christophe Claude Parsy, Francois-Rene Alexandre, Jean-Francois Griffon, Dominique Surleraux +5 more |
2019-12-24 |
| 10449208 |
Antiviral prodrugs of tenofovir |
Daniel Da Costa, Cyril B. Dousson, David Dukhan, Jean-Laurent Paparin, Izzat T. Raheem |
2019-10-22 |
| 9296778 |
3′,5′-cyclic phosphate prodrugs for HCV infection |
Christophe Claude Parsy, Francois-Rene Alexandre, Cyril B. Dousson, David Dukhan, Gilles Gosselin +1 more |
2016-03-29 |
| 9187496 |
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors |
Cyril B. Dousson, David Dukhan, Christophe Claude Parsy, Claire Pierra, Francois-Rene Alexandre +6 more |
2015-11-17 |
| 8426437 |
Pyrroloquinoline derivatives and their use as protein kinases inhibitors |
Hugues Bienayme, Antoine Dumoulin, Serge Grisoni, Bachir Kaloun El, Stéphane Poigny +5 more |
2013-04-23 |
| 8362068 |
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors |
Cyril B. Dousson, David Dukhan, Christophe Claude Parsy, Claire Pierra, Francois-Rene Alexandre +6 more |
2013-01-29 |